Clinical trial
Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease
NCT00483184 · Nobel Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00483184 |
|---|---|
| Title | Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease |
| Official title | Phase II Study, Evaluation of Low Dose Natural Human Interferon Alpha Administered by the Oral Mucosal Route in the Treatment of Behçet's Disease |
| Lead sponsor | Nobel Pharmaceuticals, Industry |
| Collaborators | Ainos, Inc. (f/k/a Amarillo Biosciences Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Behcet Syndrome, Behcet Disease, Mucocutaneous Ulceration |
| Intervention type | Biological |
| Interventions | Veldona |
| Enrollment | 84 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jun 6, 2007 |
| Last update posted | Jun 16, 2009 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: